Ha habido 23 transacciones internas recientes registradas para Heartflow, Inc. Common Stock (HTFL), incluyendo 5 compras y 18 ventas. El total de compras internas fue valorado en $13.33M y el total de ventas internas en $59.84M.
Internos destacados con actividad reciente incluyen Rogers Campbell, Healthcor Partners Management Lp, Lightcap Jeffrey C. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — HTFL
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Rogers Campbell |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
6,849 |
$2.22 |
$15.2K |
- |
| 2026-03-24 |
Healthcor Partners Management Lp |
Director |
Otro (Venta) |
4,615,542 |
- |
- |
- |
| 2026-03-24 |
Lightcap Jeffrey C |
Director |
Otro (Compra) |
206,261 |
- |
- |
246,261 |
| 2026-03-19 |
Rogers Campbell |
Chief Medical Officer |
Venta Informativa |
64,533 |
$25.69 |
$1.66M |
78,518 |
| 2026-03-18 |
Farquhar John C.m. |
Chief Executive Officer |
Venta Informativa |
9,725 |
$25.00 |
$243.13K |
571,725 |
| 2026-03-11 |
Barabe Timothy C |
Director |
Ejercicio de Opciones (Venta) |
8,667 |
$2.22 |
$19.24K |
15,412 |
| 2026-03-10 |
Farquhar John C.m. |
Chief Executive Officer |
Venta Informativa |
12,837 |
$22.66 |
$290.89K |
581,450 |
| 2026-03-06 |
Farquhar John C.m. |
Chief Executive Officer |
Concesión de RSU |
2,631 |
$16.15 |
$42.49K |
594,287 |
| 2026-03-05 |
Cullivan Julie A |
Director |
Venta Informativa |
9,122 |
$25.00 |
$228.05K |
27,291 |
| 2026-02-17 |
Barabe Timothy C |
Director |
Ejercicio de Opciones (Venta) |
2,497 |
$8.33 |
$20.8K |
- |
| 2026-02-12 |
Rogers Campbell |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
39,709 |
$8.33 |
$330.78K |
- |
| 2026-02-10 |
Farquhar John C.m. |
Chief Executive Officer |
Venta Informativa |
22,562 |
$27.46 |
$619.55K |
591,656 |
| 2026-02-06 |
Rogers Campbell |
Chief Medical Officer |
Retención Fiscal de RSU |
515 |
$27.74 |
$14.29K |
20,098 |
| 2026-02-06 |
Farquhar John C.m. |
Chief Executive Officer |
Concesión de RSU |
321,259 |
$27.74 |
$8.91M |
321,259 |
| 2026-02-06 |
Jones Marie L. |
Chief Accounting Officer, VP |
Retención Fiscal de RSU |
94 |
$27.74 |
$2.61K |
10,021 |
| 2026-02-06 |
Verghese Vikram |
Chief Financial Officer |
Concesión de RSU |
119,685 |
$27.74 |
$3.32M |
119,685 |
| 2026-02-05 |
Cullivan Julie A |
Director |
Venta Informativa |
8,000 |
$27.32 |
$218.56K |
36,413 |
| 2026-02-04 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
Venta Informativa |
2,000,000 |
$28.05 |
$56.1M |
10,448,158 |
| 2025-12-16 |
Lightcap Jeffrey C |
Director |
Compra Informativa |
40,000 |
$26.34 |
$1.05M |
40,000 |
| 2025-11-07 |
Rogers Campbell |
Chief Medical Officer |
Retención Fiscal de RSU |
439 |
$32.56 |
$14.29K |
20,613 |
| 2025-11-07 |
Farquhar John C.m. |
Chief Executive Officer |
Retención Fiscal de RSU |
1,339 |
$32.56 |
$43.6K |
431,909 |
| 2025-11-07 |
Jones Marie L. |
Chief Accounting Officer, VP |
Retención Fiscal de RSU |
81 |
$32.56 |
$2.64K |
10,115 |
| 2025-11-07 |
Verghese Vikram |
Chief Financial Officer |
Retención Fiscal de RSU |
471 |
$32.56 |
$15.34K |
144,912 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
